Spruce Biosciences, Inc. Other Non-Current Liabilities
Spruce Biosciences, Inc. (SPRB) had Other Non-Current Liabilities of $0 as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-03-09
- 2025-12-31: Other Liabilities, Noncurrent $0.00.
- 2025-09-30: Other Liabilities, Noncurrent $0.00.
- 2025-06-30: Other Liabilities, Noncurrent $0.00.
- 2025-03-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 |
| 2024-12-31 | $282.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $273.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $262.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $250.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $236.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $220.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $202.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $181.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $161.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $139.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $117.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $95.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $73.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $51.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $29.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $8.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $118.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $95.00K 10-Q · filed 2020-11-18 |
| 2019-12-31 | $20.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |